Analyst Ratings for Inovio Pharmaceuticals (INO)
INO Rating Summary
INO Price Target Summary
- Highest: $13.00 (Oppenheimer)
- Lowest: $2.50 (H.C. Wainwright)
- Average: $6.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.90 (+418.8%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
Avg. $ Target:
$6.90 (+418.8%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Jefferies | Roger Song | Upgrade | Buy (Hold) |
3.00 (1.80) |
0.77 (1.33) |
72.73% | Details |
| 11/11/2025 | Oppenheimer » Updated 3/13/2026 |
Jay Olson | Upgrade | Outperform (Outperform) |
13.00 (N/A) |
2.12 (1.33) |
-37.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
